Atlas Trials

Origin Biosciences

5 clinical trials · Sponsor

Sort:Newest firstOldest first

◉ Watch Origin Biosciences

RecordFirmDate
Study of ORGN001 (Formerly ALXN1101) in Neonates, Infants and Children With Molybdenum Cofactor Deficiency (MOCD) Type A (NCT02629393)Origin Biosciences2016-05-01
Safety & Efficacy Study of ORGN001 (Formerly ALXN1101) in Pediatric Patients With MoCD Type A Currently Treated With rcPMP (NCT02047461)Origin Biosciences2014-04-01
A Natural History Study of Molybdenum Cofactor and Isolated Sulfite Oxidase Deficiencies (NCT01735188)Origin Biosciences2013-08-01
Phase 1 Single Dose Study of ALXN1101 in Healthy Volunteers (NCT01894165)Origin Biosciences2013-06-01
A Retrospective, Observational, Noninterventional Data Collection Study for Patients With Molybdenum Cofactor Deficiency Who Have Been Previously Treated With Cyclic Pyranopterin Monophosphate (cPMP) (NCT01640717)Origin Biosciences2012-11-01

Track Origin Biosciences automatically

Every clearance here is in the API, with alerts when new ones post.